Cardiovascular Generics Portfolio

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is a vertically integrated, publicly listed Indian pharmaceutical company with a century-long legacy. It operates through two main segments: Generics and Branded Generics, with a robust manufacturing infrastructure and a growing international footprint, particularly in the US market. The company is strategically focused on complex generics, biosimilars, and specialty products to drive future growth, supported by significant R&D investments.

About SPIMACO

SPIMACO is a major player in the Saudi and MENA region pharmaceutical market, established to enhance local drug manufacturing capabilities and ensure medicine security. The company operates multiple manufacturing facilities and has a diverse portfolio spanning various therapeutic areas, including cardiology, gastroenterology, and antibiotics. As a publicly listed entity, it plays a strategic role in the Saudi Vision 2030 goals for healthcare self-sufficiency, combining local production with technology transfer from international partners.

Therapeutic Areas